Sunobinop | m-entrepreneurship.com

Product Name :
Sunobinop

Search keywords :
Sunobinop

drugId :
null

Target Vo:
Nociceptin receptor

Target Vo Short Name :
OOR

Moa_Name:
Nociceptin receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Purdue Pharma

Active Company_Name :
Imbrium Therapeutics Lp

Active Indication_Name:
Sleep Initiation and Maintenance Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKA R2 Antibody
ATG10 Antibody (YA603)
MLH1 Antibody: MLH1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to MLH1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts